Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
8.05M
-
Shares change
-
-24.1K
-
Total reported value, excl. options
-
$47.2M
-
Value change
-
-$121K
-
Number of buys
-
15
-
Number of sells
-
-11
-
Price
-
$5.87
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q3 2018
37 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q3 2018.
scPharmaceuticals Inc. - Common Stock (SCPH) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.05M shares
of 53.4M outstanding shares and own 15.08% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.41M shares), RA CAPITAL MANAGEMENT, LLC (2.86M shares), AWM Investment Company, Inc. (470K shares), BlackRock Inc. (351K shares), Alyeska Investment Group, L.P. (231K shares), Vanguard Group Inc (206K shares), STATE STREET CORP (115K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (69.5K shares), NORTHERN TRUST CORP (68.8K shares), and GEODE CAPITAL MANAGEMENT, LLC (50.3K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.